Dianthus Therapeutics

DNTH • NASDAQ • Stock Fundamentals

Dianthus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marino Garcia, with a market cap of $4.2B.

Market Cap$4.2B

Employees53.0

CEOMarino Garcia

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Dianthus Therapeutics

Dianthus Therapeutics (DNTH) has a market capitalization of $4.2B and trades on NASDAQ.

Dianthus Therapeutics has approximately 53 employees.